Company: BIAF
Filing Date: 2025-05-27
Form Type: 8-K
Source: 0001641172-25-012411
Chunk: 0

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-05-27
Form: 8-K
Item: Item 1.01
Chunk 0
---
Item
1.01. Entry into a Material Definitive Agreement.

On
May 22, 2025, bioAffinity Technologies, Inc., a Delaware corporation, (the “ Company”), entered into an At-The-Market
Issuance Sales Agreement (the “ ATM Agreement”) with WallachBeth Capital LLC (“ WallachBeth”), as sales agent providing
for the sale by the Company of its common stock, par value $0.007 per share (the “ Common Stock”), from time to time, i n
an “at the market offering” program The
sales, if any, of the shares of Common Stock made under the ATM Agreement will be made by any method permitted by law deemed to be an
“at the market offering” as defined in Rule 415 promulgated under the Securities Act of 1933, as amended (the “ Securities
Act”) including sales made directly on or through the Nasdaq Capital Market or on any other existing trading market for the Company’s
common shares, directly to WallachBeth as principal, in negotiated transactions at market prices prevailing at the time of sale or at
prices related to such prevailing market prices, and/or in any other method permitted by law.

The
shares of Common Stock, if any, will be issued pursuant to a prospectus supplement, dated May 27, 2025 (the “ ATM Prospectus
Supplement”), and an accompanying base prospectus, dated November 27, 2023, contained therein, which together form a part of the
Company’s “shelf” registration statement on Form S-3 (File No. 333-275608) filed by the Company with the Securities
and Exchange Commission (“ SEC”) on November 16, 2023 and declared effective by the SEC on November 27, 2023. The aggregate
market value of the shares of Common Stock eligible for sale under the ATM Prospectus Supplement is currently $5,801,000, which is based
on the limitations of General Instruction I. B.6 of Form S-3.

Under
the ATM Agreement, the Company will set the parameters for the sale of shares, including the number of shares to be issued, the time
period during which sales are requested to be made, limitation on the number of shares that may be sold in any one trading day and any
minimum price below which sales may not be made. Subject to the terms and conditions of the ATM Agreement, WallachBeth may sell the shares
by